Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis’s Jimenez Beats Out Reinhardt to Replace CEO Vasella
Bloomberg
Tuesday, January 26, 2010 - 7:17am
tags:
Novartis, Pharma CEOs, Daniel Vasella, Joe Jimenez
Pay-for-Delay Is Under the Spotlight
Motley Fool
Tuesday, January 26, 2010 - 7:12am
tags:
pay-for-delay, Novartis, Pfizer, Merck, Teva Pharmaceuticals, GSK, Mylan, generics
In a makeover, Quintiles to invest more in experimental drugs
Fierce Biotech
Monday, January 25, 2010 - 3:59pm
tags:
Quintiles, CROs
NY Governor To Limit Pharma Influence Over Docs
Pharmalot
Monday, January 25, 2010 - 3:57pm
tags:
New York, physicians, physician gifts
Keryx and AEterna Zentaris say perifosine improved survival compared to potential competitor
Yahoo/AP
Monday, January 25, 2010 - 3:56pm
tags:
Aeterna Zentaris, Keryx, cancer, perifosine
2010: A Big Year for Big Pharma
Seeking Alpha
Monday, January 25, 2010 - 12:40pm
tags:
Big Pharma, Pfizer, Bristol-Myers Squibb, Vertex Pharmaceuticals, Merck, Elan
Johnson & Johnson Still Loved by TheStreet
TheStreet.com
Monday, January 25, 2010 - 12:39pm
tags:
JNJ
Will generic Wellbutrin live up to brand?
Fierce Pharma
Monday, January 25, 2010 - 12:38pm
tags:
Wellbutrin XL, generics, GSK, Teva Pharmaceuticals, Biovail, Wellbutrin
Debunking the Accorda Therapeutics Merger Rumors
BNET Pharma
Monday, January 25, 2010 - 12:36pm
tags:
Acorda Therapeutics, M&A, Biogen Idec, Teva Pharmaceuticals, AMPYRA
FDA approves Biogen Idec multiple sclerosis treatment Ampyra
Bizjournals.com
Monday, January 25, 2010 - 12:35pm
tags:
MS, multiple sclerosis, Biogen Idec, FDA, AMPYRA
Earnings Preview: Amgen
Seeking Alpha
Monday, January 25, 2010 - 12:33pm
tags:
Amgen, earnings
Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug
Xconomy
Monday, January 25, 2010 - 12:32pm
tags:
Amylin, diabetes, Eli Lilly, exenatide
Auxilium Earns Milestone Payment
Yahoo/Zacks.com
Monday, January 25, 2010 - 12:31pm
tags:
Auxilium, Pfizer, Xiaflex
Earnings Preview: Johnson & Johnson
Seeking Alpha
Monday, January 25, 2010 - 12:30pm
tags:
JNJ
Earnings Preview: Abbott Laboratories to report 4Q
Yahoo/AP
Monday, January 25, 2010 - 12:29pm
tags:
earnings, Abbott Laboratories
Harvard Doc Steps Down to Keep Drug-Industry Speaking Gig
WSJ Online
Monday, January 25, 2010 - 12:27pm
tags:
physicians, physician payments, GSK
Abbott Submits New HIV Test to FDA for Expedited Review
Yahoo
Monday, January 25, 2010 - 12:26pm
tags:
Abbott Laboratories, FDA, HIV
3 Reasons to Buy Geron Today
Motley Fool
Monday, January 25, 2010 - 12:25pm
tags:
Geron, stem cells
[video] Merck's Move: One Minute Trade
TheStreet.com
Monday, January 25, 2010 - 12:11pm
tags:
Merck
Can Johnson & Johnson Heal Itself?
TheStreet.com
Monday, January 25, 2010 - 12:10pm
tags:
JNJ, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.